Randomized multi-centric trial comparing the classical double lumen endobronchial tube and the ViviSight double lumen endobronchial tube for airway management during thoracic surgery

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00010090

Enrollment

Registered

2016-04-05

Start date

2015-12-17

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer, pneumothorax C34.9 J93.9

Interventions

Group 1: Standard double lumen endobronchial tube, 37-39Ch with use of bronchoscopy Group 2: visualized double lumen endobronchial tube Vivasight, 37-39Ch, controlled by integrated camera

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: female with body hight of 150-175cm, male with body hight of 165-185cm

Exclusion criteria

Exclusion criteria: Body size others than mentioned Expected difficult airway Refusal of written informed consent

Design outcomes

Primary

Measure	Time frame
Time from start to finish of anesthesia induction, need for intraoperative control tube position Feedback directly from surgeon/anesthesist with questionnaire Feedback from Patient until 90minutes after surgery as well as first day following surgery regarding airway morbidity and wound pain.	—

Secondary

Measure	Time frame
costs per anesthesia, Evaluation of intraoperative conditions by surgeon, Evaluation of conditions by anesthesist	—

Countries

Germany

Contacts

Public ContactSebastian Russo

Klinik für AnästhesiologieUniversitätsmedizin Göttingen

sebastian.russo@med.uni-goettingen.de0551398899

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026